211 related articles for article (PubMed ID: 37143953)
1. Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma.
He Y; Wu Y; Song M; Yang Y; Yu Y; Xu S
Front Oncol; 2023; 13():1149370. PubMed ID: 37143953
[TBL] [Abstract][Full Text] [Related]
2. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis.
Wang W; Pan F; Lin X; Yuan J; Tao C; Wang R
Front Genet; 2022; 13():907331. PubMed ID: 35938001
[No Abstract] [Full Text] [Related]
3. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
Li X; Lin J; Pan Y; Cui P; Xia J
Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
[No Abstract] [Full Text] [Related]
4. A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma.
Liang JY; Wang DS; Lin HC; Chen XX; Yang H; Zheng Y; Li YH
Int J Biol Sci; 2020; 16(13):2430-2441. PubMed ID: 32760210
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Prognosis and Molecular Mechanism of Ferroptosis in Hepatocellular Carcinoma Based on Bioinformatics Methods.
Xiong Y; Ouyang Y; Fang K; Sun G; Tu S; Xin W; Wei Y; Xiao W
Comput Math Methods Med; 2022; 2022():4558782. PubMed ID: 35774297
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis and cuproptosis prognostic signature for prediction of prognosis, immunotherapy and drug sensitivity in hepatocellular carcinoma: development and validation based on TCGA and ICGC databases.
Ma Q; Hui Y; Huang BR; Yang BF; Li JX; Fan TT; Gao XC; Ma DY; Chen WF; Pei ZX
Transl Cancer Res; 2023 Jan; 12(1):46-64. PubMed ID: 36760376
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma.
Wang L; Ge X; Zhang Z; Ye Y; Zhou Z; Li M; Yan H; Wu L; Bai Q; Li J; Zhu J; Wang Y
Front Genet; 2021; 12():682082. PubMed ID: 34745200
[No Abstract] [Full Text] [Related]
8. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
[TBL] [Abstract][Full Text] [Related]
9. A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma.
Li G; Liu Y; Zhang Y; Xu Y; Zhang J; Wei X; Zhang Z; Zhang C; Feng J; Li Q; Wang G
Front Immunol; 2022; 13():929089. PubMed ID: 35874689
[TBL] [Abstract][Full Text] [Related]
10. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
[TBL] [Abstract][Full Text] [Related]
11. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis of ferroptosis-related gene signature for overall survival prediction in Asian patients with hepatocellular carcinoma.
Wang Z; Zhang L; Xu J; Song W
Clin Transl Oncol; 2023 Mar; 25(3):721-730. PubMed ID: 36319928
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma.
Wang Q; Wang B; Ma X; Zhuang H; Xie Z; Tang C; Tan W; Yang L; Shang C; Chen Y
J Hepatocell Carcinoma; 2023; 10():1-16. PubMed ID: 36647389
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma.
Yang X; Mei M; Yang J; Guo J; Du F; Liu S
Aging (Albany NY); 2022 May; 14(9):4069-4084. PubMed ID: 35550563
[TBL] [Abstract][Full Text] [Related]
15. Identification and Validation of Ferroptosis-Related Subtypes and a Predictive Signature in Hepatocellular Carcinoma.
Zheng C; Peng Y; Wang H; Wang Y; Liu L; Zhao Q
Pharmgenomics Pers Med; 2023; 16():39-58. PubMed ID: 36726530
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma.
Ma X; Yu S; Zhao B; Bai W; Cui Y; Ni J; Lyu Q; Zhao J
Front Immunol; 2022; 13():922315. PubMed ID: 35774794
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma.
Shi J; Wu P; Sheng L; Sun W; Zhang H
Cancer Cell Int; 2021 Dec; 21(1):669. PubMed ID: 34906147
[TBL] [Abstract][Full Text] [Related]
18. Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma.
Zhang Z; Zhang W; Wang Y; Wan T; Hu B; Li C; Ge X; Lu S
Front Cell Dev Biol; 2022; 10():792676. PubMed ID: 35295858
[TBL] [Abstract][Full Text] [Related]
19. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma.
Huang EM; Ma N; Ma T; Zhou JY; Yang WS; Liu CX; Hou ZH; Chen S; Zong Z; Zeng B; Li YR; Zhou TC
World J Gastrointest Oncol; 2022 Oct; 14(10):1981-2003. PubMed ID: 36310708
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
